Lataa...
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh
BACKGROUND: Coronavirus disease (COVID)-19 has devasted the healthcare delivery system as well as social establishments of almost all countries of the world. However, vaccines for containing new cases of COVID-19 are yet to be realized. Also, presently available antiviral drugs and other standard of...
Tallennettuna:
| Julkaisussa: | Euroasian J Hepatogastroenterol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Jaypee Brothers Medical Publishers
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7801887/ https://ncbi.nlm.nih.gov/pubmed/33511068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10018-1327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|